Real-Time Quote
Enter Company or MF
Ranbaxy Laboratories Ltd. - Research Center
Results |
|
Statement |
P&L
|
More |
|
(Rs crore)
Profit loss account
| | Dec ' 08 | Dec ' 07 | Dec ' 06 | Dec ' 05 | Dec ' 04 |
Income |
| Operating income | 4,652.04 | 4,293.02 | 4,165.12 | 3,640.50 | 3,791.28 |
Expenses |
| Material consumed | 1,933.72 | 1,820.51 | 1,663.53 | 1,536.59 | 1,483.86 |
| Manufacturing expenses | 203.48 | 172.95 | 160.22 | 136.64 | 131.35 |
| Personnel expenses | 472.65 | 420.04 | 328.45 | 298.38 | 324.01 |
| Selling expenses | 597.47 | 601.76 | 540.91 | 536.28 | 530.92 |
| Adminstrative expenses | 1,193.59 | 877.79 | 839.94 | 950.11 | 692.44 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 4,400.91 | 3,893.06 | 3,533.06 | 3,458.00 | 3,162.60 |
| Operating profit | 251.13 | 399.97 | 632.06 | 182.49 | 628.69 |
| Other recurring income | 91.28 | 17.18 | 30.33 | 23.46 | 28.13 |
| Adjusted PBDIT | 342.41 | 417.15 | 662.39 | 205.95 | 656.82 |
| Financial expenses | 145.83 | 93.43 | 58.44 | 26.41 | 10.98 |
| Depreciation | 154.47 | 118.73 | 106.75 | 101.33 | 81.85 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 42.12 | 204.99 | 497.20 | 78.20 | 563.99 |
| Tax charges | -574.24 | 156.69 | 62.43 | -22.34 | 99.87 |
| Adjusted PAT | 616.36 | 48.30 | 434.77 | 100.54 | 464.13 |
| Non recurring items | -1,678.92 | 533.95 | -58.98 | 98.79 | 36.65 |
| Other non cash adjustments | 17.76 | 35.46 | 19.34 | 12.72 | 26.74 |
| Reported net profit | -1,044.80 | 617.72 | 395.13 | 212.04 | 527.52 |
| Earnigs before appropriation | -828.53 | 664.84 | 451.16 | 439.05 | 884.54 |
| Equity dividend | - | 317.15 | 316.89 | 316.67 | 316.26 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | 53.90 | 44.44 | 44.41 | 44.04 |
| Retained earnings | -828.53 | 293.78 | 89.82 | 77.97 | 524.24 |